Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Troubled Halol plant earns Sun a US FDA Form 483

The US FDA has issued Sun Pharmaceutical Industries with a Form 483 citing problems identified at its plant in Halol.

WHO commits to source drugs and vaccines from 'green' suppliers

The WHO has agreed to source drugs from manufacturers which use sustainable production methods.

US drug reimportation 'Trump proposal' risky and inefficient, AmerisourceBergen

AmerisourceBergan has warned of the dangers of reimportation a day after the Senate rejected Bernie Sanders’ “Trump proposal” to overturn the ban.

Mylan says cost cutting plan will impact up to 10% of its staff

Mylan NV has announced a restructuring plan that it says will impact less than 10% of its workforce.

News in brief

Fareva opens aerosol plant as part of $40m drug and OTC business investment

Fareva Group has set up an aerosol manufacturing facility at its site in Richmond, Virginia as part of a $40m (€37m) investment in its drug, OTC medicine and beauty care business.

Lonza to sell therapeutic peptides business to PolyPeptide

Lonza has agreed to sell its therapeutic peptide business to PolyPeptide Laboratories in a deal that will also see the latter firm take on 280 staff.

US FDA says Interquim's API plant remediation plan is inadequate

The US FDA has asked Spanish API firm Interquim S.A. for more details of its plan to bring its Barcelona manufacturing plant up to code.

GSK extends single-use purification tech R&D deal with Puridify

The development partnership has been extended as GlaxoSmithKline looks to make clinical trial scale batches using Puridify’s Protein A alternative to packed bed chromatography columns.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...